(February 11, 2020, 10:11 AM EST) -- ST. LOUIS — A $4.69 billion asbestos-talc ovarian cancer verdict was not the prejudicial mess of improperly admitted experts, misapplied standards and a confused jury portrayed by Johnson & Johnson, plaintiffs in Missouri told a state appeals court on Dec. 19 (Gail Ingham, et al. v. Johnson & Johnson, et al., No. ED 107476, Mo. App., Eastern Dist.)....